🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.4831
-0.0880 (-15.41%)
At close: Nov 18, 2026, 4:00 PM EST
0.5001
+0.0170 (3.52%)
Pre-market: Nov 19, 2026, 7:07 AM EST

Celularity Revenue

Celularity had revenue of $5.43M in the quarter ending June 30, 2026, a decrease of -5.30%. This brings the company's total for the last twelve months to $18.67M, down -58.14% year-over-year. In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. That makes Celularity the 34,296th largest company in the world by revenue and 4,499th in the United States.

Revenue (ttm)
$18.67M
Revenue Growth
-58.14%
P/S Ratio
0.84
Revenue / Employee
$162,313
Employees
115
Market Cap
15.68M

Revenue Chart

Revenue by Segment

  • Degenerative Disease 17.31M 65.2%
  • Biobanking 5.43M 20.5%
  • Cell Therapy 3.81M 14.3%
Fiscal year ended Dec 31, 2025 See the full Celularity breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202526.55M-27.67M-51.03%
Dec 31, 202454.22M31.45M138.11%
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M--
Dec 31, 2019---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.